![]() |
市場調查報告書
商品編碼
1258915
到 2028 年的自動分析儀市場預測——分析儀、機翼類型、應用、最終用戶和地區的全球分析Automated Analyzers Market Forecasts to 2028 - Global Analysis By Analyzer, Wing Type, Application, End User and By Geography |
根據Stratistics MRC,2022年全球自動化分析儀市場規模將達到75億美元,預計2028年將達到127億美元,預測期內增長9.1%。預計將以 CAGR 增長。
醫學實驗室儀器,稱為自動分析儀,旨在快速有效地測量大量收集的生物樣本中的各種化學成分和其他參數,而無需或很少有人為乾預。 它還適用於醫院、門診診所、外科和急診室。
據世界衛生組織稱,傳染病是世界上最主要的死亡原因,每年造成超過 1300 萬人死亡,其中二分之一的死亡發生在欠發達國家。
傳染病的傳播給醫療保健資源帶來了巨大的壓力。 嗜酸性粒細胞沉降率 (ESR) 檢測的增加也可能部分歸因於感染的增加,感染繼續帶來各種健康風險。 此外,政府的需求和對綜合醫療保健系統日益增長的需求是市場擴張的主要因素。
自動分析儀是一個複雜的系統,需要專業知識來維護和操作。 規模較小或技術較不先進的醫療機構可能面臨這樣的挑戰,因為他們沒有必要的人員和資源來有效地使用這些系統。 這些系統的校準和維護不當可能導致測試結果不准確、診斷或治療不當。 因此,這些因素可能會阻礙市場需求。
使用機器學習、機器人技術和人工智能等尖端技術的實驗室自動化意味著自動化實驗室任務,例如樣品製備、分析和數據管理。 由於其許多好處,例如提高效率、準確性、可重複性、降低勞動力成本和周轉時間,實驗室自動化正在迅速獲得採用並推動市場增長。
公司應大力投資培訓員工以有效使用這些工具。 因此,在員工不具備必要技能的環境中,部署可能會受到限制,因此,部署可能會在一定程度上受到限制。 然而,自動分析儀產品的高價格、勞動力短缺和自動分析儀的複雜性預計會阻礙市場擴張。
許多政府實施的 COVID-19 大流行措施增加了對自動分析儀的需求,尤其是對診斷測試。 自動化分析儀可以快速準確地進行各種診斷,包括用於檢測 SARS-CoV-2 的核酸擴增測試。 受非典疫情影響需求激增,自動分析儀為提高檢測能力、縮短檢測時間做出了巨大貢獻。
由於臨床化學和免疫測定的需求不斷增長,預計免疫系統分析儀將實現利潤豐厚的增長。 稱為免疫系統分析儀的醫療設備會自動測試患者標本以檢測生物活性成分。 這些分析儀主要用於診斷癌症、心髒病、自身免疫性疾病、傳染病等。 免疫化學分析儀市場的發展有望擴大該領域的市場。
由於在基因組學中使用了自動化分析儀,預計基因組學部分在預測期內將以最快的複合年增長率增長。 這比手動分析更準確,表明大多數操作可以按順序完成。 以合理的成本及時獲取大量數據是許多研究的主要目標之一。 文庫創建、測序和重複標記均由自動化基因組分析儀執行。
由於人們對心臟分析、過敏測試、血液計數等的認識不斷提高,亞太地區預計在預測期內將佔據最大的市場份額。 此外,醫療保健意識的提高、製藥公司的增加以及血液病患者的增加有望促進該行業的發展。
由於醫療保健基礎設施的改善以及主要製造商對研發活動的投資不斷增加,預計北美在預測期內的複合年增長率最高。 此外,由於政府加大了對診斷分析儀自動化的力度,以及許多化學和製藥行業在其研發業務中引入了自動化分析儀,預計該地區的市場將會增長。
自動化分析儀市場的主要參與者包括:Hudson Robotics Inc.、Thermo Fisher Scientific、Honeywell International Inc.、Tecan Group Ltd.、Becton Dickinson、Siemens Healthineers AG、Danaher Corporation , PerkinElmer Inc. Synchron Lab Automation, Agilent Technologies Inc, HORIBA Ltd., ELITechGroup, Ortho Clinical Diagnostics, Aurora Biomed, Eppendorf AG, Yokogawa Electric Corporation
2021 年 2 月,橫河電機株式會社與 Hiroto Savio-Science Co., Ltd. (HBS) 共同宣布了癌症篩查服務“N-”,旨在擴大 NOSE 的使用範圍,我們簽署了一項投資合作協議。
2019 年 9 月,Thermo Fisher Scientific 宣布推出先進的高效液相色譜 (HPLC) 和三重四極桿質譜分析,用於對複雜樣品基質中的農藥進行可靠、靈敏的定量分析。我們設計了一種新的工作流程,提供經過驗證的分析方法結合了 (MS) 功能。
購買此報告的客戶將免費獲得以下定制之一。
According to Stratistics MRC, the Global Automated Analyzers Market is accounted for $7.5 billion in 2022 and is expected to reach $12.7 billion by 2028 growing at a CAGR of 9.1% during the forecast period. A medical laboratory device called an automated analyzer may be created to quickly and effectively measure various chemical compositions and other parameters in a large number of gathered biological samples with little help from humans. Tools also allow for the examination of a wide variety of samples and the quick generation of data, indicating future uses for them in hospitals, outpatient clinics, and surgical as well as emergency wards.
According to the WHO, infectious diseases are the world's leading cause of death, accounting for more than 13 million deaths per year, with one in every two deaths occurring in underdeveloped nations.
The resources used by healthcare services are put under tremendous strain by the rising prevalence of infectious diseases. The increased number of Eosinophil Sedimentation Rate (ESR) tests is likely due in part to the increasing number of infectious infections that are continuously causing various health risks. Also, the requirements from the respective governments and the rising need for integrated healthcare systems are significant drivers of the market's expansion.
Automatic analyzers are frequently intricate systems that call for unique expertise to maintain and operate. Smaller or less technologically advanced healthcare providers could find this challenging since they do not have the staff or resources they need to use these systems efficiently. Inaccuracies in test results and improper diagnosis or treatment may come from improper calibration and upkeep of these systems. Thus, this factor may impede demand for the market.
Using cutting-edge technology like machine learning, robots, and artificial intelligence, laboratory automation entails automating operations in the lab, such as sample preparation, analysis, and data management. Laboratory automation is quickly being adopted because it provides numerous benefits such as enhanced efficiency, precision, and reproducibility, as well as lowers labour costs and turnaround time, which are driving market growth.
Businesses need to make significant investments in training their staff members on how to use these tools efficiently. This may limit their adoption in environments where staff could lack the necessary skills, which in turn may limit their acceptance to some extent. Yet the high cost of automated analyzer products, the labour shortage, and the increasing sophistication of automated analyzers will prove to be obstacles to the market's expansion.
The COVID-19 pandemic lockdown measures put in place by many governments have raised demand for automated analyzers, notably for diagnostic testing. Automatic analyzers may swiftly and accurately carry out a variety of diagnostic procedures, such as nucleic acid amplification tests for finding SARS-CoV-2, the virus that causes the disease. Throughout the epidemic, demand has increased dramatically, and automated analyzers have been crucial in boosting testing capacity and speeding up turnaround times.
The immuno-based analyzer segment is estimated to have a lucrative growth, due to growing demand in clinical chemistry and immunoassay. Medical devices called immuno-based analyzers automatically conduct tests on patient samples to find any biologically active components. These analyzers are mostly employed in the diagnosis of cancer, cardiac, autoimmune, and infectious illnesses. The market is anticipated to expand in this sector due to the development of immunochemistry analyzers.
The Genomics segment is anticipated to witness the fastest CAGR growth during the forecast period, due to the uses of automated analyzers in genomics. This indicates that the majority of operations can be completed in a sequential manner with more accuracy than manual analysis. Getting a lot of data in a timely manner at a fair cost is one of the main objectives for many studies. The creation of libraries, sequencing, and duplication marking are all tasks performed by automated analyzers in genomics.
Asia Pacific is projected to hold the largest market share during the forecast period owing to rise in the consciousness among the people about cardiac analysis, allergy testing, blood cell counts and others. In addition, rising healthcare awareness, an increase in the number of pharmaceutical firms in the area, and an increase in the number of patients with blood disorders are all expected to help the industry develop.
North America is projected to have the highest CAGR over the forecast period, owing to the existence of improved healthcare infrastructure and major manufacturers increasing the investments in R&D activities. Also, the region's market is expected to develop as a result of the government's increased efforts to automate diagnosis analyzers and the large number of chemical and pharmaceutical industries who have adopted automated analyzers for R&D operations.
Some of the key players profiled in the Automated Analyzers Market include: Hudson Robotics Inc., Thermo Fisher Scientific, Honeywell International Inc., Tecan Group Ltd., Becton Dickinson, Siemens Healthineers AG, Danaher Corporation, PerkinElmer Inc., Synchron Lab Automation, Agilent Technologies Inc., HORIBA, Ltd., ELITechGroup, Ortho Clinical Diagnostics, Aurora Biomed, Eppendorf AG and Yokogawa Electric Co., Ltd.
In February 2021, Yokogawa Electric Co., Ltd. and HIROT SUBIO SCIENCE (HBS) have signed an investment partnership agreement with the aim of expanding the use of HBS's N-NOSE cancer screening service, which detects cancer using the highly sensitive olfactory function of nematodes.
In September 2019, Thermo Fisher Scientific designed a new workflow to provide a validated analytical method combining advanced high-performance liquid chromatography (HPLC) and triple quadrupole mass spectrometry (MS) capabilities for the reliable and sensitive quantitation of pesticides in complex sample matrices.
All the customers of this report will be entitled to receive one of the following free customization options: